Tumor necrosis factor-α regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosis

Velidi H. Rao, Vikrant Rai, Samantha Stoupa, Saravanan Subramanian, Devendra K. Agrawal

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective: To determine the relationship between increased triggering receptor expressed on myeloid cells (TREM)-1 and plaque stability in atherosclerotic carotid stenosis. Methods: The mRNA transcripts and protein for TREM-1, MMP-1, MMP-9, collagen type I (COL1A1) and collagen type III (COL3A1) were analyzed by qPCR and immunofluorescence in both tissues and VSMCs isolated from atherosclerotic carotid plaques of symptomatic and asymptomatic patients with carotid stenosis. Results: The TREM-1, MMP-1 and MMP-9 mRNA transcripts were significantly increased (TREM-1, p <0.01; MMP-1, p <0.01 and MMP-9, p <0.001) while COL1A1 and COL3A1 mRNA transcripts were decreased (p <0.001) in VSMCs isolated from carotid plaques of symptomatic (S) than asymptomatic (AS) patients. Stimulation of cells with TNF-α further increased the mRNA transcripts of TREM-1, MMPs, COL1A1 and COL3A1. Modulation of TREM-1 by treatment with TREM-1 decoy receptor rTREM-1/Fc, and either TREM-1 antibodies or TREM-1 siRNA attenuated the TNF-α-induced expression of MMP-1 and MMP-9 (p <0.01) and COL1A1 and COL3A1 (p <0.01) in S compared to AS VSMCs isolated from carotid plaques. Inhibition of NF-kB (BAY 11-7085), JNK (SP600125) and PI3K (LY294002) signaling pathways decreased the expression of TREM-1 (p <0.01), MMP-1 (p <0.001) and MMP-9 (p <0.01) in TNF-α-treated VSMCs isolated from S carotid plaques compared to AS patients. Conclusion: Increased expression of TREM-1 in S compared to AS patients involving MMP-1 and MMP-9 suggest a potential role of TREM-1 in plaque destabilization. Selective blockade of TREM-1 may contribute to the development of new therapies and promising targets for stabilizing vulnerable atherosclerotic plaques.

Original languageEnglish
Pages (from-to)160-169
Number of pages10
JournalAtherosclerosis
Volume248
DOIs
StatePublished - May 1 2016

Fingerprint

Matrix Metalloproteinase 1
Carotid Stenosis
Myeloid Cells
Matrix Metalloproteinases
Tumor Necrosis Factor-alpha
Messenger RNA
Atherosclerotic Plaques
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Collagen Type III
NF-kappa B
Collagen Type I
Phosphatidylinositol 3-Kinases

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Tumor necrosis factor-α regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosis. / Rao, Velidi H.; Rai, Vikrant; Stoupa, Samantha; Subramanian, Saravanan; Agrawal, Devendra K.

In: Atherosclerosis, Vol. 248, 01.05.2016, p. 160-169.

Research output: Contribution to journalArticle

@article{81d5385abe8a4bfab6f267be865ca8df,
title = "Tumor necrosis factor-α regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosis",
abstract = "Objective: To determine the relationship between increased triggering receptor expressed on myeloid cells (TREM)-1 and plaque stability in atherosclerotic carotid stenosis. Methods: The mRNA transcripts and protein for TREM-1, MMP-1, MMP-9, collagen type I (COL1A1) and collagen type III (COL3A1) were analyzed by qPCR and immunofluorescence in both tissues and VSMCs isolated from atherosclerotic carotid plaques of symptomatic and asymptomatic patients with carotid stenosis. Results: The TREM-1, MMP-1 and MMP-9 mRNA transcripts were significantly increased (TREM-1, p <0.01; MMP-1, p <0.01 and MMP-9, p <0.001) while COL1A1 and COL3A1 mRNA transcripts were decreased (p <0.001) in VSMCs isolated from carotid plaques of symptomatic (S) than asymptomatic (AS) patients. Stimulation of cells with TNF-α further increased the mRNA transcripts of TREM-1, MMPs, COL1A1 and COL3A1. Modulation of TREM-1 by treatment with TREM-1 decoy receptor rTREM-1/Fc, and either TREM-1 antibodies or TREM-1 siRNA attenuated the TNF-α-induced expression of MMP-1 and MMP-9 (p <0.01) and COL1A1 and COL3A1 (p <0.01) in S compared to AS VSMCs isolated from carotid plaques. Inhibition of NF-kB (BAY 11-7085), JNK (SP600125) and PI3K (LY294002) signaling pathways decreased the expression of TREM-1 (p <0.01), MMP-1 (p <0.001) and MMP-9 (p <0.01) in TNF-α-treated VSMCs isolated from S carotid plaques compared to AS patients. Conclusion: Increased expression of TREM-1 in S compared to AS patients involving MMP-1 and MMP-9 suggest a potential role of TREM-1 in plaque destabilization. Selective blockade of TREM-1 may contribute to the development of new therapies and promising targets for stabilizing vulnerable atherosclerotic plaques.",
author = "Rao, {Velidi H.} and Vikrant Rai and Samantha Stoupa and Saravanan Subramanian and Agrawal, {Devendra K.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.atherosclerosis.2016.03.021",
language = "English",
volume = "248",
pages = "160--169",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Tumor necrosis factor-α regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosis

AU - Rao, Velidi H.

AU - Rai, Vikrant

AU - Stoupa, Samantha

AU - Subramanian, Saravanan

AU - Agrawal, Devendra K.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Objective: To determine the relationship between increased triggering receptor expressed on myeloid cells (TREM)-1 and plaque stability in atherosclerotic carotid stenosis. Methods: The mRNA transcripts and protein for TREM-1, MMP-1, MMP-9, collagen type I (COL1A1) and collagen type III (COL3A1) were analyzed by qPCR and immunofluorescence in both tissues and VSMCs isolated from atherosclerotic carotid plaques of symptomatic and asymptomatic patients with carotid stenosis. Results: The TREM-1, MMP-1 and MMP-9 mRNA transcripts were significantly increased (TREM-1, p <0.01; MMP-1, p <0.01 and MMP-9, p <0.001) while COL1A1 and COL3A1 mRNA transcripts were decreased (p <0.001) in VSMCs isolated from carotid plaques of symptomatic (S) than asymptomatic (AS) patients. Stimulation of cells with TNF-α further increased the mRNA transcripts of TREM-1, MMPs, COL1A1 and COL3A1. Modulation of TREM-1 by treatment with TREM-1 decoy receptor rTREM-1/Fc, and either TREM-1 antibodies or TREM-1 siRNA attenuated the TNF-α-induced expression of MMP-1 and MMP-9 (p <0.01) and COL1A1 and COL3A1 (p <0.01) in S compared to AS VSMCs isolated from carotid plaques. Inhibition of NF-kB (BAY 11-7085), JNK (SP600125) and PI3K (LY294002) signaling pathways decreased the expression of TREM-1 (p <0.01), MMP-1 (p <0.001) and MMP-9 (p <0.01) in TNF-α-treated VSMCs isolated from S carotid plaques compared to AS patients. Conclusion: Increased expression of TREM-1 in S compared to AS patients involving MMP-1 and MMP-9 suggest a potential role of TREM-1 in plaque destabilization. Selective blockade of TREM-1 may contribute to the development of new therapies and promising targets for stabilizing vulnerable atherosclerotic plaques.

AB - Objective: To determine the relationship between increased triggering receptor expressed on myeloid cells (TREM)-1 and plaque stability in atherosclerotic carotid stenosis. Methods: The mRNA transcripts and protein for TREM-1, MMP-1, MMP-9, collagen type I (COL1A1) and collagen type III (COL3A1) were analyzed by qPCR and immunofluorescence in both tissues and VSMCs isolated from atherosclerotic carotid plaques of symptomatic and asymptomatic patients with carotid stenosis. Results: The TREM-1, MMP-1 and MMP-9 mRNA transcripts were significantly increased (TREM-1, p <0.01; MMP-1, p <0.01 and MMP-9, p <0.001) while COL1A1 and COL3A1 mRNA transcripts were decreased (p <0.001) in VSMCs isolated from carotid plaques of symptomatic (S) than asymptomatic (AS) patients. Stimulation of cells with TNF-α further increased the mRNA transcripts of TREM-1, MMPs, COL1A1 and COL3A1. Modulation of TREM-1 by treatment with TREM-1 decoy receptor rTREM-1/Fc, and either TREM-1 antibodies or TREM-1 siRNA attenuated the TNF-α-induced expression of MMP-1 and MMP-9 (p <0.01) and COL1A1 and COL3A1 (p <0.01) in S compared to AS VSMCs isolated from carotid plaques. Inhibition of NF-kB (BAY 11-7085), JNK (SP600125) and PI3K (LY294002) signaling pathways decreased the expression of TREM-1 (p <0.01), MMP-1 (p <0.001) and MMP-9 (p <0.01) in TNF-α-treated VSMCs isolated from S carotid plaques compared to AS patients. Conclusion: Increased expression of TREM-1 in S compared to AS patients involving MMP-1 and MMP-9 suggest a potential role of TREM-1 in plaque destabilization. Selective blockade of TREM-1 may contribute to the development of new therapies and promising targets for stabilizing vulnerable atherosclerotic plaques.

UR - http://www.scopus.com/inward/record.url?scp=84962554425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962554425&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2016.03.021

DO - 10.1016/j.atherosclerosis.2016.03.021

M3 - Article

VL - 248

SP - 160

EP - 169

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

ER -